Trial Profile
Clinical Trials Insight: 700030192
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2008
Price :
$35
*
At a glance
- Drugs S-nitrosoglutathione (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Cystic fibrosis
- Focus Adverse reactions
- Sponsors N30 Pharma
- 30 Jan 2008 New trial record.